27649667|t|LncRNA MIAT enhances cardiac hypertrophy partly through sponging miR-150
27649667|a|In this work, we aimed to study whether myocardial infarction associated transcript (MIAT) exerts a regulative effect on cardiac hypertrophy via acting as a miR-150 sponge. Cardiac hypertrophy was induced using Angiotensin II (Ang II). MIAT and miR-150 expression were quantified using qRT-PCR. Rat heart - derived H9c2 cells were used as the in vitro model. Cardiac hypertrophic features were assessed by quantifying cardiac hypertrophic genes and measurement of cell surface, protein synthesis and total protein content. MIAT is significantly increased in Ang II induced cardiac hypertrophy in a mouse model and in H9c2 cells. MIAT siRNA substantially alleviated the Ang II induced upregulation of ANP, BNP and β-MHC in H9c2 cells and markedly attenuated the Ang II induced increase of the cell surface area and the protein synthesis. MIAT overexpression in H9c2 cells significantly reduced the miR-150 expression. MIAT inhibition also partly restored the miR-150 levels under Ang II treatment. MiR-150 overexpression could attenuate the Ang II induced upregulation of hypertrophic marker genes and suppress the Ang II induced hypertrophic phenotypes of the cells. MIAT is significantly increased in Ang II induced cardiac hypertrophy and contributes to the pathological development. MIAT can suppress miR-150 expression in cardiomyocytes and miR-150 is a downstream effector of MIAT in the development of cardiac hypertrophy.
27649667	0	11	LncRNA MIAT	T114	C1870266
27649667	12	20	enhances	T052	C2349975
27649667	21	40	cardiac hypertrophy	T046	C1383860
27649667	65	72	miR-150	T028	C1537805
27649667	113	156	myocardial infarction associated transcript	T114	C1870266
27649667	158	162	MIAT	T114	C1870266
27649667	173	183	regulative	T038	C1327622
27649667	184	190	effect	T080	C1280500
27649667	194	213	cardiac hypertrophy	T046	C1383860
27649667	230	237	miR-150	T028	C1537805
27649667	246	265	Cardiac hypertrophy	T046	C1383860
27649667	270	277	induced	T169	C0205263
27649667	284	298	Angiotensin II	T116,T121,T123	C0003009
27649667	300	306	Ang II	T116,T121,T123	C0003009
27649667	309	313	MIAT	T114	C1870266
27649667	318	325	miR-150	T028	C1537805
27649667	326	336	expression	T045	C0017262
27649667	342	352	quantified	T081	C1709793
27649667	359	366	qRT-PCR	T063	C1514628
27649667	368	377	Rat heart	T023	C1882687
27649667	380	387	derived	T080	C1441547
27649667	388	398	H9c2 cells	T025	C1135917
27649667	416	430	in vitro model	T062	C1515654
27649667	432	452	Cardiac hypertrophic	T046	C1383860
27649667	467	475	assessed	T052	C1516048
27649667	479	490	quantifying	T081	C1709793
27649667	491	511	cardiac hypertrophic	T046	C1383860
27649667	512	517	genes	T028	C0017337
27649667	522	533	measurement	T169	C0242485
27649667	537	549	cell surface	T026	C0699040
27649667	551	568	protein synthesis	T044	C0597295
27649667	579	586	protein	T116,T123	C0033684
27649667	587	594	content	T081	C1264655
27649667	596	600	MIAT	T114	C1870266
27649667	618	627	increased	T081	C0205217
27649667	631	637	Ang II	T116,T121,T123	C0003009
27649667	638	645	induced	T169	C0205263
27649667	646	665	cardiac hypertrophy	T046	C1383860
27649667	671	682	mouse model	T050	C2986594
27649667	690	700	H9c2 cells	T025	C1135917
27649667	702	706	MIAT	T114	C1870266
27649667	707	712	siRNA	T114,T123	C1099354
27649667	742	748	Ang II	T116,T121,T123	C0003009
27649667	749	756	induced	T169	C0205263
27649667	757	769	upregulation	T044	C0041904
27649667	773	776	ANP	T028	C1417807
27649667	778	781	BNP	T028	C1417808
27649667	786	791	β-MHC	T028	C0017337
27649667	795	805	H9c2 cells	T025	C1135917
27649667	819	829	attenuated	T052	C0599946
27649667	834	840	Ang II	T116,T121,T123	C0003009
27649667	841	848	induced	T169	C0205263
27649667	849	857	increase	T169	C0442805
27649667	865	877	cell surface	T026	C0699040
27649667	878	882	area	T082	C0205146
27649667	891	908	protein synthesis	T044	C0597295
27649667	910	914	MIAT	T114	C1870266
27649667	915	929	overexpression	T045	C1514559
27649667	933	943	H9c2 cells	T025	C1135917
27649667	958	965	reduced	T080	C0392756
27649667	970	977	miR-150	T028	C1537805
27649667	978	988	expression	T045	C0017262
27649667	990	994	MIAT	T114	C1870266
27649667	995	1005	inhibition	T052	C3463820
27649667	1031	1038	miR-150	T028	C1537805
27649667	1039	1045	levels	T080	C0441889
27649667	1052	1058	Ang II	T116,T121,T123	C0003009
27649667	1059	1068	treatment	T169	C1522326
27649667	1070	1077	MiR-150	T028	C1537805
27649667	1078	1092	overexpression	T045	C0017262
27649667	1099	1108	attenuate	T052	C0599946
27649667	1113	1119	Ang II	T116,T121,T123	C0003009
27649667	1120	1127	induced	T169	C0205263
27649667	1128	1140	upregulation	T044	C0041904
27649667	1144	1156	hypertrophic	T046	C0020564
27649667	1157	1163	marker	T201	C0005516
27649667	1164	1169	genes	T028	C0017337
27649667	1174	1182	suppress	T169	C1260953
27649667	1187	1193	Ang II	T116,T121,T123	C0003009
27649667	1194	1201	induced	T169	C0205263
27649667	1202	1214	hypertrophic	T046	C0020564
27649667	1215	1225	phenotypes	T032	C0031437
27649667	1233	1238	cells	T025	C0007634
27649667	1240	1244	MIAT	T114	C1870266
27649667	1262	1271	increased	T081	C0205217
27649667	1275	1281	Ang II	T116,T121,T123	C0003009
27649667	1282	1289	induced	T169	C0205263
27649667	1290	1309	cardiac hypertrophy	T046	C1383860
27649667	1333	1345	pathological	T169	C1521733
27649667	1346	1357	development	T169	C1527148
27649667	1359	1363	MIAT	T114	C1870266
27649667	1368	1376	suppress	T169	C1260953
27649667	1377	1384	miR-150	T028	C1537805
27649667	1385	1395	expression	T045	C0017262
27649667	1399	1413	cardiomyocytes	T025	C0225828
27649667	1418	1425	miR-150	T028	C1537805
27649667	1454	1458	MIAT	T114	C1870266
27649667	1466	1477	development	T169	C1527148
27649667	1481	1500	cardiac hypertrophy	T046	C1383860